5 studies found for: "hutchinson-gilford progeria syndrome"
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
|3||Active, not recruiting||
Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Clinical Studies of Progeria
A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
† Indicates status has not been verified in more than two years